Surabhi Kandaswamy

Dr. Surabhi Kandaswamy

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2023 in Genomics
Verified
Journal Article
Open access
CRC.T. Dhanya Raj
C.T. Dhanya Raj
MSMangesh Suryavanshi
Mangesh Suryavanshi
SKSurabhi Kandaswamy
Surabhi Kandaswamy
KRKesava Priyan Ramasamy
Kesava Priyan Ramasamy
ARArthur James Rathinam
Arthur James Rathinam
In this study, the probiotic potential of B. velezensis FCW2, isolated from naturally fermented coconut water, was investigated by in vitro and genomic characterization. Our findings highlight key features of the bacterium which includes, antibacterial activity, high adhesive potential, aggregation capacity, production of nutrient secondary metabolites. In vivo safety assessment revealed no adverse effects on zebrafish. WGS data of B. velezensis FCW2 revealed a complete circular genome of 4,147,426 nucleotides and a GC content of 45.87%. We have identified 4059 coding sequence (CDS) genes that encode proteins involved in stress resistance, adhesion and micronutrient production. The genes responsible for producing secondary metabolites, exopolysaccharides, and other beneficial nutrients were identified. The KEGG and COG databases revealed that genes mainly involved amino acid metabolism, carbohydrate utilization, vitamin and cofactor metabolism, and biological adhesion. These findings suggest that B. velezensis FCW2 could be a putative probiotic in the development of fermented foods.

Verified
Journal Article
Open access
PDF file
SKSurabhi Kandaswamy
Surabhi Kandaswamy
MPMakarla Venkata Sathya Prakash
Makarla Venkata Sathya Prakash
JGJochen Graw
Jochen Graw
SKSamuel Koller
Samuel Koller
IMIstván Magyar
István Magyar
SSSathiyaveedu Thyagarajan Santhiya
Sathiyaveedu Thyagarajan Santhiya
Congenital cataracts are the prime cause for irreversible blindness in children. The global incidence of congenital cataract is 2.2–13.6 per 10,000 births, with the highest prevalence in Asia. Nearly half of the congenital cataracts are of familial nature, with a predominant autosomal dominant pattern of inheritance. Over 38 of the 45 mapped loci for isolated congenital or infantile cataracts have been associated with a mutation in a specific gene. The clinical and genetic heterogeneity of congenital cataracts makes the molecular diagnosis a bit of a complicated task. Hence, whole exome sequencing (WES) was utilized to concurrently screen all known cataract genes and to examine novel candidate factors for a disease-causing mutation in probands from 11 pedigrees affected with familial congenital cataracts. Analysis of the WES data for known cataract genes identified causative mutations in six pedigrees (55%) in PAX6, FYCO1 (two variants), EPHA2, P3H2,TDRD7 and an additional likely causative mutation in a novel gene NCOA6, which represents the first dominant mutation in this gene. This study identifies a novel cataract gene not yet linked to human disease. NCOA6 is a transcriptional coactivator that interacts with nuclear hormone receptors to enhance their transcriptional activator function.

17 September 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
SKSurabhi Kandaswamy
Surabhi Kandaswamy
LZLena Zobel
Lena Zobel
BJBina John
Bina John
SSSathiyavedu Thyagarajan Santhiya
Sathiyavedu Thyagarajan Santhiya
JBJacqueline Bogedein
Jacqueline Bogedein
OAOana Veronica Amarie
Oana Veronica Amarie
Retinitis pigmentosa is a group of progressive inherited retinal dystrophies that may present clinically as part of a syndromic entity or as an isolated (nonsyndromic) manifestation. In an Indian family suffering from retinitis pigmentosa, we identified a missense variation in CNGA1 affecting the cyclic nucleotide binding domain (CNBD) and characterized a mouse model developed with mutated CNBD. A gene panel analysis comprising 105 known RP genes was used to analyze a family with autosomal-recessive retinitis pigmentosa (arRP) and revealed that CNGA1 was affected. From sperm samples of ENU mutagenesis derived F1 mice, we re-derived a mutant with a Cnga1 mutation. Homozygous mutant mice, developing retinal degeneration, were examined for morphological and functional consequences of the mutation. In the family, we identified a rare CNGA1 variant (NM_001379270.1) c.1525 G > A; (p.Gly509Arg), which co-segregated among the affected family members. Homozygous Cnga1 mice harboring a (ENSMUST00000087213.12) c.1526 A > G (p.Tyr509Cys) mutation showed progressive degeneration in the retinal photoreceptors from 8 weeks on. This study supports a role for CNGA1 as a disease gene for arRP and provides new insights on the pathobiology of cGMP-binding domain mutations in CNGA1-RP.

1 January 2021 in Therapeutic Advances in Rare Disease
Verified
Journal Article
Open access
PDF file
WNWing Sum Vincent Ng
Wing Sum Vincent Ng
MTMatthieu Trigano
Matthieu Trigano
TFThomas Freeman
Thomas Freeman
CVCarmine Varrichio
Carmine Varrichio
SKSurabhi Kandaswamy
Surabhi Kandaswamy
Marcela VotrubaMarcela Votruba
Marcela Votruba
Mitochondrial optic neuropathies are a group of optic nerve atrophies exemplified by the two commonest conditions in this group, autosomal dominant optic atrophy (ADOA) and Leber’s hereditary optic neuropathy (LHON). Their clinical features comprise reduced visual acuity, colour vision deficits, centro-caecal scotomas and optic disc pallor with thinning of the retinal nerve fibre layer. The primary aetiology is genetic, with underlying nuclear or mitochondrial gene mutations. The primary pathology is owing to retinal ganglion cell dysfunction and degeneration. There is currently only one approved treatment and no curative therapy is available. In this review we summarise the genetic and clinical features of ADOA and LHON and then examine what new avenues there may be for therapeutic intervention. The therapeutic strategies to manage LHON and ADOA can be split into four categories: prevention, compensation, replacement and repair. Prevention is technically an option by modifying risk factors such as smoking cessation, or by utilising pre-implantation genetic diagnosis, although this is unlikely to be applied in mitochondrial optic neuropathies due to the non-life threatening and variable nature of these conditions. Compensation involves pharmacological interventions that ameliorate the mitochondrial dysfunction at a cellular and tissue level. Replacement and repair are exciting new emerging areas. Clinical trials, both published and underway, in this area are likely to reveal future potential benefits, since new therapies are desperately needed. Plain language summary: Optic nerve damage leading to loss of vision can be caused by a variety of insults. One group of conditions leading to optic nerve damage is caused by defects in genes that are essential for cells to make energy in small organelles called mitochondria. These conditions are known as mitochondrial optic neuropathies and two predominant examples are called autosomal dominant optic atrophy and Leber’s hereditary optic neuropathy. Both conditions are caused by problems with the energy powerhouse of cells: mitochondria. The cells that are most vulnerable to this mitochondrial malfunction are called retinal ganglion cells, otherwise collectively known as the optic nerve, and they take the electrical impulse from the retina in the eye to the brain. The malfunction leads to death of some of the optic nerve cells, the degree of vision loss being linked to the number of those cells which are impacted in this way. Patients will lose visual acuity and colour vision and develop a central blind spot in their field of vision. There is currently no cure and very few treatment options. New treatments are desperately needed for patients affected by these devastating diseases. New treatments can potentially arise in four ways: prevention, compensation, replacement and repair of the defects. Here we explore how present and possible future treatments might provide hope for those suffering from these conditions.

8 February 2021 in Archives of Microbiology
Verified
Journal Article
Open access
PDF file
CRC. T. Dhanya Raj
C. T. Dhanya Raj
SKSurabhi Kandaswamy
Surabhi Kandaswamy
RDRavi Chandra Sekhara Reddy Danduga
Ravi Chandra Sekhara Reddy Danduga
RRRaju Rajasabapathy
Raju Rajasabapathy
ARArthur James Rathinam
Arthur James Rathinam
The Covid-19 pandemic is highly contagious and has spread rapidly across the globe. To date there have been no specific treatment options available for this life-threatening disease. During this medical emergency, target-based drug repositioning/repurposing with a continuous monitoring and recording of results is an effective method for the treatment and drug discovery. This review summarizes the recent findings on COVID-19, its genomic organization, molecular evolution through phylogenetic analysis and has recapitulated the drug targets by analyzing the viral molecular machinery as drug targets and repurposing of most frequently used drugs worldwide and their therapeutic applications in COVID-19. Data from solidarity trials have shown that the treatment with Chloroquine, hydroxychloroquine and lopinavir-ritonavir had no effect in reducing the mortality rate and also had adverse side effects. Remdesivir, Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19. Recent clinical trial has revealed that dexamethasone and convalescent plasma treatment can reduce mortality in patients with severe forms of COVID-19.

2 October 2021 in Agenda
Verified
Journal Article
Closed access
LBLEKHA BHAT
LEKHA BHAT
SKSurabhi Kandaswamy
Surabhi Kandaswamy
BSB.S. Sumalatha
B.S. Sumalatha
GMGayathree Mohan
Gayathree Mohan
OTOurania Vamvaka Tatsi
Ourania Vamvaka Tatsi
This article explores the fear, stigma, discrimination, work-life balance, household dynamics, and healthcare access of women domestic workers in India during the COVID-19 pandemic. The women domestic workers interviewed mainly belonged to the lower strata of society, where survival is mainly based on day-to-day earnings. The pandemic has substantially changed the workplace environment, and the vulnerability of women has increased tremendously. Women report sleeplessness, a trust deficit, and experiences of loss of self-dignity. Economic insecurity is widely reported, which in turn affects social life and quality of life. It is evident that instances of fear and anxiety are due to a lack of safety at the workplace and drastically reduced income levels. Instances of loss of basic dignity at the workplace or while travelling to the workplace are also widely shared. Women reported a significant increase in the workload at home, decreased intake of food, and reduced healthcare seeking. Lack of rest and self-care is the first change that women reported, because the long time spent on home and work responsibilities are taken for granted by other members of the family. Women also reported increased incidences of domestic violence and sexual abuse. This is mainly because, in this patriarchal society, men are ventilating their frustration about joblessness, wage reduction, and alcohol non-availability due to the pandemic on women at home. Psychological stress, confusion, and restlessness were commonly observed during our conversations. The majority of women either discontinued or stopped their ongoing treatment both for reproductive health and chronic diseases during the pandemic, due to non-affordability and lack of other support. This article argues that women domestic workers endured fear, stigma, loss of dignity, domestic violence, sexual abuse, and compromised self-care during the pandemic, and the male-dominated society is normalising such practices.